- Breast
- Lung
- Gastrointestinal
- Genitourinary
- Leukemia
- Lymphoma
- Myeloma
- Hematologic Malignancies
- Head and Neck
- General Oncology
- Palliative Care
- Events
Playback speed
10 seconds
Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approved Selpercatinib & Pralsetinib
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
76 views
March 4, 2021
Comments 0
Login to view comments.
Click here to Login